Clearside Biomedical Inc (CLSD)

1.03 -0.02 (-1.90%) USD  |  NASDAQ  |  Nov 21, 16:00
1.03 0.00 (0.00%) After-Hours: 19:17
More

Clearside Biomedical Price to Book Value

Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2016. Upgrade now.
Date Value
June 29, 2023 26.72
June 28, 2023 28.09
June 27, 2023 27.86
June 26, 2023 28.32
June 23, 2023 28.55
June 22, 2023 29.92
June 21, 2023 30.38
June 20, 2023 30.38
June 16, 2023 33.80
June 15, 2023 31.98
June 14, 2023 30.38
June 13, 2023 28.78
June 12, 2023 29.01
June 09, 2023 29.23
June 08, 2023 29.23
June 07, 2023 28.78
June 06, 2023 29.01
June 05, 2023 26.27
June 02, 2023 26.27
June 01, 2023 25.58
May 31, 2023 24.67
May 30, 2023 24.21
May 26, 2023 24.44
May 25, 2023 23.98
May 24, 2023 25.12
Date Value
May 23, 2023 25.12
May 22, 2023 24.89
May 19, 2023 23.30
May 18, 2023 23.07
May 17, 2023 23.75
May 16, 2023 23.75
May 15, 2023 24.44
May 12, 2023 23.98
May 11, 2023 24.67
May 10, 2023 26.49
May 09, 2023 24.67
May 08, 2023 25.35
May 05, 2023 23.07
May 04, 2023 22.17
May 03, 2023 22.73
May 02, 2023 22.38
May 01, 2023 22.84
April 28, 2023 23.07
April 27, 2023 23.30
April 26, 2023 24.10
April 25, 2023 24.44
April 24, 2023 25.12
April 21, 2023 24.21
April 20, 2023 25.58
April 19, 2023 26.27

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

2.138
Minimum
Mar 10 2022
33.80
Maximum
Jun 16 2023
10.75
Average
9.221
Median
May 07 2021

Price to Book Value Benchmarks

Perspective Therapeutics Inc 0.6153
Viking Therapeutics Inc 6.316
Atara Biotherapeutics Inc --
Corvus Pharmaceuticals Inc 46.27
Crinetics Pharmaceuticals Inc 6.346

Price to Book Value Related Metrics

PS Ratio 9.418
Price 1.03
Earnings Yield -43.69%
Market Cap 78.12M